[HTML][HTML] Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy
GV Papatheodoridis, HLY Chan, BE Hansen… - Journal of …, 2015 - Elsevier
In the treatment of chronic hepatitis B (CHB), the ultimate goal is preventing hepatitis B virus
(HBV)-associated liver disease, including hepatocellular carcinoma (HCC). Recently …
(HBV)-associated liver disease, including hepatocellular carcinoma (HCC). Recently …
Hepatocellular carcinoma.
Liver cancer is the second leading cause of cancer-related deaths globally and has an
incidence of approximately 850,000 new cases per year. Hepatocellular carcinoma (HCC) …
incidence of approximately 850,000 new cases per year. Hepatocellular carcinoma (HCC) …
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …
epidemiology due to several factors including vaccination policies and migration. This …
PAGE-B predicts the risk of develo** hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
Background & Aims Risk scores for hepatocellular carcinoma (HCC) developed in Asians
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
[HTML][HTML] Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
Background & Aims A recent consensus document has defined metabolic dysfunction-
associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight …
associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight …
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
Background & Aims Several models have recently been developed to predict risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …
Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
MB Zeisel, J Lucifora, WS Mason, C Sureau, J Beck… - Gut, 2015 - gut.bmj.com
HBV infection is a major cause of liver cirrhosis and hepatocellular carcinoma. Although
HBV infection can be efficiently prevented by vaccination, and treatments are available, to …
HBV infection can be efficiently prevented by vaccination, and treatments are available, to …
Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis
Background & Aims Current guidelines recommend biannual surveillance for hepatocellular
carcinoma (HCC) in all patients with cirrhosis, regardless of etiology. However, HCC …
carcinoma (HCC) in all patients with cirrhosis, regardless of etiology. However, HCC …
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Abstract Background & Aims Oral antiviral therapy may reduce the disease progression of
chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy of long‐term …
chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy of long‐term …
Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
BACKGROUND Efficacy trials have shown that antiviral therapy improves the outcomes of
patients with chronic hepatitis B virus (HBV) infection. However, prospective data regarding …
patients with chronic hepatitis B virus (HBV) infection. However, prospective data regarding …